MAPK signalling in cellular metabolism: stress or wellness? H Gehart, S Kumpf, A Ittner, R Ricci EMBO reports 11 (11), 834-840, 2010 | 331 | 2010 |
Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice A Ittner, SW Chua, J Bertz, A Volkerling, J Van Der Hoven, A Gladbach, ... Science 354 (6314), 904-908, 2016 | 276 | 2016 |
Dendritic tau in Alzheimer’s disease A Ittner, LM Ittner Neuron 99 (1), 13-27, 2018 | 237 | 2018 |
Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice M Bi, A Ittner, YD Ke, J Götz, LM Ittner PloS one 6 (12), e26860, 2011 | 188 | 2011 |
Lessons from tau‐deficient mice YD Ke, AK Suchowerska, J Van Der Hoven, DM De Silva, CW Wu, ... International journal of Alzheimer’s disease 2012 (1), 873270, 2012 | 164 | 2012 |
Tau‐targeted treatment strategies in Alzheimer's disease J Götz, A Ittner, LM Ittner British journal of pharmacology 165 (5), 1246-1259, 2012 | 162 | 2012 |
Tau exacerbates excitotoxic brain damage in an animal model of stroke M Bi, A Gladbach, J Van Eersel, A Ittner, M Przybyla, A Van Hummel, ... Nature communications 8 (1), 473, 2017 | 157 | 2017 |
Neuronal network disintegration: common pathways linking neurodegenerative diseases RM Ahmed, EM Devenney, M Irish, A Ittner, S Naismith, LM Ittner, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (11), 1234-1241, 2016 | 152 | 2016 |
Functions of p38 MAP kinases in the central nervous system PR Asih, E Prikas, K Stefanoska, ARP Tan, HI Ahel, A Ittner Frontiers in molecular neuroscience 13, 570586, 2020 | 107 | 2020 |
Regulation of PTEN activity by p38δ-PKD1 signaling in neutrophils confers inflammatory responses in the lung A Ittner, H Block, CA Reichel, M Varjosalo, H Gehart, G Sumara, ... Journal of Experimental Medicine 209 (12), 2229-2246, 2012 | 101 | 2012 |
Tau‐targeting passive immunization modulates aspects of pathology in tau transgenic mice A Ittner, J Bertz, LS Suh, CH Stevens, J Götz, LM Ittner Journal of neurochemistry 132 (1), 135-145, 2015 | 88 | 2015 |
p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease AA Ittner, A Gladbach, J Bertz, LS Suh, LM Ittner Acta Neuropathologica Communications 2, 1-17, 2014 | 85 | 2014 |
An N-terminal motif unique to primate tau enables differential protein–protein interactions K Stefanoska, A Volkerling, J Bertz, A Poljak, YD Ke, LM Ittner, A Ittner Journal of Biological Chemistry 293 (10), 3710-3719, 2018 | 61 | 2018 |
Brief update on different roles of tau in neurodegeneration A Ittner, YD Ke, J Eersel, A Gladbach, J Götz, LM Ittner IUBMB life 63 (7), 495-502, 2011 | 58 | 2011 |
Generation of a new tau knockout (tau Δex1) line using CRISPR/Cas9 genome editing in mice D Tan, S Yao, A Ittner, J Bertz, YD Ke, LM Ittner, F Delerue Journal of Alzheimer's Disease 62 (2), 571-578, 2018 | 50 | 2018 |
Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia M Przybyla, CH Stevens, J van der Hoven, A Harasta, M Bi, A Ittner, ... Neuroscience letters 631, 24-29, 2016 | 50 | 2016 |
No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice A Van Hummel, M Bi, S Ippati, J Van Der Hoven, A Volkerling, WS Lee, ... PLoS One 11 (10), e0163236, 2016 | 48 | 2016 |
Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation K Stefanoska, M Gajwani, ARP Tan, HI Ahel, PR Asih, A Volkerling, ... Science advances 8 (27), eabl8809, 2022 | 47 | 2022 |
Mouse models of frontotemporal dementia: a comparison of phenotypes with clinical symptomatology RM Ahmed, M Irish, J van Eersel, A Ittner, YD Ke, A Volkerling, ... Neuroscience & Biobehavioral Reviews 74, 126-138, 2017 | 36 | 2017 |
Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviour K Stefanoska, J Bertz, AM Volkerling, J van der Hoven, LM Ittner, A Ittner Scientific reports 8 (1), 14296, 2018 | 33 | 2018 |